Full text is available at the source.
Abstract
Three months of tirzepatide treatment may influence kidney function in adults with obesity.
- Obesity is linked to chronic kidney disease through metabolic changes and inflammation.
- Tirzepatide is known for its effectiveness in promoting weight loss and improving metabolic health.
- Data on tirzepatide's effects on kidney function in real-world settings is currently limited.
- The study aims to assess changes in estimated glomerular filtration rate (eGFR) after tirzepatide treatment.
Simplified